The global Friedreich’s ataxia market is experiencing notable growth, fueled by advancements in genetic research, enhanced diagnostic technologies, and increased awareness of this rare ...

The FDA has issued an emergency use authorization for lotilaner chewable tablets (Credelio CAT; Elanco Animal Health) for treating New World screwworm (NWS) infestations in cats and kittens. Credelio ...

MUM Nicky Starkowitz felt like she’d been “hit by a train” when her son Raffi was handed his cancer diagnosis. The only clue ...

A fast-spreading horse virus is forcing West Texas owners, arenas and officials to tighten precautions to prevent a ...

Biohaven (EXCHANGE:BHVN) Chief Executive Officer Vlad Coric acquired 666,666 common shares in two transactions on November 13, 2025, at a price of $7.50 per share, for a total value of $4,999,995. The ...

The purchase was made by John W Childs 2013 Revocable Trust. Following the transaction, the trust holds 5,653,904 common shares of Biohaven Ltd.

Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a full-service cell and gene ...

The DVLA has confirmed a list of 118 conditions that all motorists must declare to avoid being penalised. This is the ...

The Oxford-Harrington Rare Disease Centre ('OHC') today announced the recipients of the 2025 Rare Disease Scholar Award, which advances promising discoveries from academic labs into clinical practice.

Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat rare and ultra-rare diseases OXFORD, England ...

Non-exclusive license providing Solid's proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a full-service cell and gene therapy Contract Development and Manufacturing Organizatio ...

Momentum building around tau: expect VY7523 clinical data and VY1706 clinical entry in 2026 - - Sharpened focus on ...